In the published article, there was an error. Due to our mistakes in editing process, the statistical data in the Abstract is not the final correct version, but the data and conclusions in the body text and tables are correct version. A correction has been made to Results section of Abstract.
This sentence previously stated:
“The Chinese New Year public holiday was associated with an increase in mean blood glucose (8.4 ± 1.7 vs. 9.2 ± 2.5; P < 0.001) and time above range (TAR) (27.9% ± 16.6% vs. 35.0% ± 22.3%; P< 0.001) but a decrease in time in range (TIR) (65.1% ± 15.5% vs. 58.0% ± 19.0%; P < 0.001) and coefficient of variation (CV) (65.1% ± 15.5% vs.58.0% ± 19.0%; P < 0.001). There was no significant difference in time below range (TBR)”.
The corrected sentence appears below:
“The Chinese New Year public holiday was associated with an increase in mean blood glucose (8.2 ± 1.9 vs. 8.9± 2.8; P < 0.001) and time above range (TAR) (26.1% ± 18.1% vs. 31.7% ± 23.9%; P< 0.001) but a decrease in time in range (TIR) (65.7% ± 16.8% vs. 59.9% ± 21.1%; P < 0.001) and coefficient of variation (CV) (38.2% ± 8.2% vs. 36.7% ± 7.7%; P =0.037). There was no statistically significant difference in time below range (TBR)”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
type 1 diabetes mellitus, glycemic control, flash glucose monitoring, holiday effect, continuous subcutaneous insulin infusion
Citation
Guo K, Ye J, Zhang L, Tian Q, Fan L, Ding Z, Zhou Q, Li X, Zhou Z and Yang L (2022) Corrigendum: Effect of the Chinese New Year public holiday on the glycemic control of T1DM with intensive insulin therapy. Front. Endocrinol. 13:985199. doi: 10.3389/fendo.2022.985199
Received
03 July 2022
Accepted
08 July 2022
Published
25 July 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2022 Guo, Ye, Zhang, Tian, Fan, Ding, Zhou, Li, Zhou and Yang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lin Yang, yanglin_nfm@csu.edu.cn
This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.